Avoro Capital Advisors LLC lifted its position in shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Free Report) by 11.0% during the fourth quarter, Holdings Channel reports. The firm owned 4,355,555 shares of the company’s stock after acquiring an additional 430,555 shares during the period. Avoro Capital Advisors LLC’s holdings in Taysha Gene Therapies were […]
Cantor Fitzgerald restated their overweight rating on shares of Taysha Gene Therapies (NASDAQ:TSHA – Free Report) in a report issued on Tuesday morning, Benzinga reports. They currently have a $7.00 target price on the stock. A number of other equities research analysts have also recently issued reports on the stock. Piper Sandler began coverage on […]
Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) has been assigned a consensus rating of “Buy” from the nine ratings firms that are presently covering the firm, MarketBeat reports. Nine equities research analysts have rated the stock with a buy recommendation. The average 1 year price objective among analysts that have covered the stock […]